Turnstone Biologics Corporation (TSBX) - היקף יתרות המזומנים של החברה

Cancer immunotherapy development is proceeding within a secure jurisdiction supported by stable international cooperation. Turnstone Biologics (TSBX) relies on lymphocyte selection to combat solid tumors while striving for pricing leadership. However, the costs of personalized manufacturing and testing uncertainties create risks. The cash structure on this GURU.Markets platform chart is fixed at 0.02, confirming current financial stability.
פילוחים אנליטיים של חברת Turnstone Biologics

This indicator reflects the dynamics of liquid assets, allowing for an assessment of capital management efficiency and the rate of cash burn. By analyzing the history of cash volume changes, an investor determines the stability of the company's financial reserve. The metric measures the balance between resource accumulation and operational expenditure. For Turnstone Biologics (TSBX), this is critical due to the high cost of cell therapy trials. Monitoring cash balances ensures uninterrupted biomaterial logistics under high-risk conditions.